Navigating Highly Potent Drugs To Clinic: Best Practices From API To Drug Product
Navigating Highly Potent Drugs To Clinic: Best Practices From API To Drug Product
Developing and manufacturing highly potent drugs presents significant challenges but it also represents a major opportunity for biotech companies looking to bring new treatments to patients. However, handling these highly potent materials requires expertise, specific equipment and organizational and technical measures to ensure control occupational exposure and to avoid cross-contamination to ensure worker safety and patient safety. Navigating the journey of a highly potent drug from Active Pharmaceutical Ingredient (HPAPI) to a finished drug product can be complex and risky. This webinar aims to provide a comprehensive overview of the best practices applied at Ardena, offering pharmaceutical companies effective control strategies to ensure safe process development and manufacture.
Topics to be covered include: the regulatory framework for HPAPI handling, the assessment of occupational exposure limits, the selection of phase-appropriate manufacturing strategies for HPAPI and potent drugs with focus on effective handling and containment strategies to minimize the risk of exposure to personnel and cross contamination.
By attending this webinar, you will gain a comprehensive understanding of the key factors to consider when developing and manufacturing highly potent drugs, as well as the best practices to ensure their success. Whether you are a startup or an established biotech company, this webinar will provide you with the knowledge and skills you need to make informed decisions and take your highly potent drugs from the laboratory to the clinic.
Topics to be covered include: the regulatory framework for HPAPI handling, the assessment of occupational exposure limits, the selection of phase-appropriate manufacturing strategies for HPAPI and potent drugs with focus on effective handling and containment strategies to minimize the risk of exposure to personnel and cross contamination.
By attending this webinar, you will gain a comprehensive understanding of the key factors to consider when developing and manufacturing highly potent drugs, as well as the best practices to ensure their success. Whether you are a startup or an established biotech company, this webinar will provide you with the knowledge and skills you need to make informed decisions and take your highly potent drugs from the laboratory to the clinic.
